Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...
  • 3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...
  • 3/30/2026AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP
  • 3/30/2026GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
  • 3/30/2026Abbisko Wins FDA Orphan Drug Designation for ABSK061 in Achondroplasia
  • 3/30/2026Kailera Files for IPO to Fund China-Licensed Obesity Pipeline
  • 3/30/2026Insilico Lands Landmark $2.75B Lilly Deal as AI Drug Discovery Momentu...
  • 3/27/2026Recent Executive Moves
  • 3/27/2026SK Biopharma Launches Epilepsy Drug Cenobamate in China
  • 3/27/2026GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
  • 3/27/2026Jiangsu Aidea Targets Hong Kong IPO to Accelerate Global Expansion in ...
  • 3/27/2026China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
  • 3/27/2026Insilico and Tenacia Expand AI-Driven Collaboration in CNS Drug Disco...
  • 3/27/2026CStone Reports Promising Clinical Progress for Trispecific Antibody CS...
  • 3/27/2026Pinnacle Medicines Secures $89M Series B to Advance Oral Peptide Pipel...
  • 3/26/2026Kelun-Biotech Secures IND Approval for SKB-103 in Advanced Solid Tumor...
  • 3/26/2026China Issues New Guidelines to Standardize Pharmaceutical Logistics Na...
  • 3/26/2026CSPC Reports Promising Phase 1 Data for B7-H3 ADC SYS6043 in Nasophary...
  • 3/26/2026Novo Nordisk 'Triple-G' Diabetes Candidate Advances to Phase 3 in Chin...
  • 3/25/2026Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...
  • 3/25/2026China Seeks Public Input on Accelerating National Drug Traceability Sy...
  • 3/25/2026China Suspends Imports of Select Indian APIs Over GMP Violations
  • 3/25/2026BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...
  • 3/25/2026Castalysis Secures Pre-A Funding to Advance alphaCas Gene Editing Plat...
  • 3/25/2026Cellgenes Raises CNY 100M+ Pre-C to Advance Stem Cell Therapy Pipeline
  • 3/25/2026Insilico Launches PandaClaw to Streamline AI-Driven Drug Discovery
  • 3/25/2026Gilead Nears $2B Ouro Deal Anchored by China-Origin BCMA/CD3 Asset
  • 3/25/2026Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD
  • 3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
  • 3/24/2026LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...
  • Page:7/62 Total number of articles:1845: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group